Misplaced Pages

Revision as of 10:50, 17 October 2013

This article has not yet been rated on Misplaced Pages's content assessment scale. It is of interest to the following WikiProjects:

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details. Companies This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany ??? This article has not yet received a rating on the project's importance scale. WikiProject Companies To-do: Here are some tasks awaiting attention: Article requests : Misplaced Pages:Requested articles/Business and economics/Companies Assess : Category:Unassessed company articles Copyedit : Category:Company articles needing attention Infobox : Category:Company articles needing infoboxes Maintain : Portal:Companies Stubs : Help expand stub articles located at Category:Company stubs Other : Tag company articles with the {{portal|Companies}} template Tag company talk pages with the {{WikiProject Companies}} project banner Answer requests for comments Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details. Business This article is within the scope of WikiProject Business, a collaborative effort to improve the coverage of business articles on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.BusinessWikipedia:WikiProject BusinessTemplate:WikiProject BusinessWikiProject Business ??? This article has not yet received a rating on the project's importance scale. Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details. Pharmacology High‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology High This article has been rated as High-importance on the project's importance scale. Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details. Switzerland High‑importance This article is within the scope of WikiProject Switzerland, a collaborative effort to improve the coverage of Switzerland on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.SwitzerlandWikipedia:WikiProject SwitzerlandTemplate:WikiProject SwitzerlandSwitzerland High This article has been rated as High-importance on the project's importance scale.

General

The meaning of the following two sentences are unclear to me (I would edit them but am unsure what the intent is or facts are): 1-"Renamed to Novartis following an acquisition by Ciba-Geigy, it owns Sandoz, a large manufacturer of generic drugs. " (who/which company is "it" referring to? Should this sentence read: "Renamed to Novartis following ITS acquisition by Ciba-Geigy, NOVARTIS ALSO owns Sandoz, a large manufacturer of generic drugs." ?) 2-"In 1996 this company merged with Sandoz, with the pharmaceutical divisions of both staying together to form Novartis, other Ciba-Geigy businesses being spun off as independent companies." (the latter part)Blue cannonball splash (talk) 20:09, 2 July 2012 (UTC)

Ciba Geigy

This page redirects from Ciba-Geigy. This seems wrong to me, as the Ciba-Geigy / Sandoz merger led to:

- Novartis being created by merging the pharma divisions.
- Syngenta being created out of Ciba Ag division.
- Ciba Specialty Chemicals being created out of Additives (and Polymers?)
          - Ciba SC was recently acquired by BASF.

Ciba Geigy was not simply renamed "Novartis" after a merger with Sandoz - I believe the above divisions were *never* part of the combined Novartis, and there may be more to the above than I have listed. —Preceding unsigned comment added by 72.5.24.11 (talk) 15:29, 12 March 2010 (UTC)

Sandoz

This article says that Sandoz produces generics. I thought Sandoz became Novartis. SO Sandoz is still around under the name Sandoz? Jaberwocky6669 July 1, 2005 03:19 (UTC)

No, some time after the merger, Novartis relaunched their generics under the brandname "Sandoz". The Sandoz company before the merger and the Novartis Sandoz brand have totaly differend product ranges. (the generics from both merger companies) 81.221.97.181 03:30, 27 March 2006 (UTC)

1986 Chemical Spill?

The page List of Environmental Disasters points to the Novartis page in reference to the Sandoz chemical spill into the Rhine River in 1986. However, there is merely a passing reference to the incident, with no details. If someone is able to add a summary of the incident that briefly describes the environmental and human health effects, it would make the link from the aforementioned page much more valuable. (I will see if I can find the time to do so, but if someone else has done the research already, a one-paragraph summary would be great.) —Preceding unsigned comment added by 70.27.72.52 (talk) 18:12, 5 May 2010 (UTC)

BBC documentary

This company was mentioned regarding indian drug trials as part of a BBC documentary broadcast today. Could someone more familar with wikipedia write something about this

http://news.bbc.co.uk/2/hi/south_asia/4932188.stm

Cheers,

JHJPDJKDKHI! 20:17, 27 April 2006 (UTC)

There is also http://www.msf.org/petition_india/international.html from Médecins Sans Frontières --Jerome Potts 06:14, 16 January 2007 (UTC)

Gerber Foods

Gerber Foods has been sold to Nestlé few days ago.

http://www.foodproductiondaily-usa.com/news/ng.asp?n=75670-nestle-gerber-acquisition-baby-food

I don't speak, and also write, english so well, so could somebody do the modification.

216.99.39.31 16:51, 14 April 2007 (UTC)

Criticism

The impending outcome of the novartis court action in India has not been mentioned. http://news.bbc.co.uk/2/hi/south_asia/6358721.stm A court challenge to India's patent laws by the pharmaceutical giant Novartis.89.100.250.181 09:48, 18 April 2007 (UTC)

I removed the POV dispute since the outcome of the court decision has since been added to the article. Koifishkid (talk) 00:12, 25 July 2009 (UTC)

Fair use rationale for Image:NOVARTISLOGO.png

Image:NOVARTISLOGO.png is being used on this article. I notice the image page specifies that the image is being used under fair use but there is no explanation or rationale as to why its use in this Misplaced Pages article constitutes fair use. In addition to the boilerplate fair use template, you must also write out on the image description page a specific explanation or rationale for why using this image in each article is consistent with fair use.

Please go to the image description page and edit it to include a fair use rationale. Using one of the templates at Misplaced Pages:Fair use rationale guideline is an easy way to insure that your image is in compliance with Misplaced Pages policy, but remember that you must complete the template. Do not simply insert a blank template on an image page.

If there is other other fair use media, consider checking that you have specified the fair use rationale on the other images used on this page. Note that any fair use images uploaded after 4 May, 2006, and lacking such an explanation will be deleted one week after they have been uploaded, as described on criteria for speedy deletion. If you have any questions please ask them at the Media copyright questions page. Thank you.BetacommandBot 04:50, 5 June 2007 (UTC)

Huntingdon Life Sciences

Hello, I would like to add a section about Novartis and Huntingdon Life Sciences and the animal rights campaign, Stop Huntingdon Animal Cruelty. Here is what I have so far: "Novartis has come under lots of fire because they are one of Huntingdon Life Science's biggest customers. Since 1999, Novartis offices have been vandalized and even firebombed. In addition, there have been lots of home pickets at Novartis executive’s homes, which still continue today." Carniv (talk) 22:26, 13 March 2008 (UTC)

Name

where the name Novartis come from? —Preceding unsigned comment added by 205.181.102.108 (talk) 17:47, 12 May 2008 (UTC)

The Name comes from NOVA ARTE and means New Art refering to the new ways to produce pharmaka.

I didn't know how to responde so i just put it in here.

Bion

Add Bion (http://en.wikipedia.org/Acibenzolar-S-methyl) to list of products? —Preceding unsigned comment added by 129.215.149.97 (talk) 11:29, 14 November 2008 (UTC)

Corporate conscience

Time, 9 March 2009, has an article discussing Novartis making Coartem. Novartis does not make a profit, in fact it makes a loss when it makes this drug. It is a drug that suits poor countries and people because it cures malaria instead of preventing it. —Preceding unsigned comment added by 124.168.45.7 (talk) 03:05, 10 May 2009 (UTC)

Order of ownership

Ref the statement: "Renamed to Novartis following an acquisition by Ciba-Geigy, it owns Sandoz, a large manufacturer of generic drugs. "

What was "renamed" to Novartis following an acquisition? You do not rename a non-existing entity, unless there was a differently named body that Ciba-Geigy acquired and then renamed it "Novartis".

I wish to suggest that the facts are actually different. According to Edgar Schein, who was a consultant to Ciba-Geigy for almost 10 years, Ciba-Geigy merged with a former competitor called Sandoz and the resulting company was later renamed Novartis. (cf. Schein, E.H. (2010) Organizational Culture and Leadership, Jossey-Bass. p.44) — Preceding unsigned comment added by Agboifo (talk • contribs) 17:32, 18 September 2012 (UTC)

edits by Meaghanvegan

Hi User: Meaghanvegan you appear to be upset about the court action in India and perhaps other controversial actions by Novartis. The changes you made were a) moving the controversies section to the top of the article and b) changes to the section on court challenges in India, specifically changing the section header from "Challenge to India's patent laws" to "Preventing Indian citizens from access to cheaper generic medicines" and c) making the Doctors Without Borders source into a "main". I discuss each of these below, separated out so we can talk about them one by one. Jytdog (talk) 09:46, 17 October 2013 (UTC)

1. The first change is arguably WP:Tendentious - instead of there being an NPOV description of the company's history, its business model, its products, and then controversies, as there is with most company articles, you moved the controversies high into the article, just below the history section. It should stay where it was, as per the standard style. Would you please explain how it complies with WP:NPOV and normal company article style, to move the controversies high into the article? Jytdog (talk) 09:46, 17 October 2013 (UTC)
2. The second change, to the section header, changed a more or less NPOV header "Challenge to India's patent laws" to a clearly POV "Preventing Indian citizens from access to cheaper generic medicines". India's patent law is new, and was structured in such a way that it was not possible for companies to obtain patents in India that they have been able to obtain elsewhere. From the perspective of the companies, this was not optimal, and - being free as anyone else to use the court system - they did so. The header "Challenge to India's patent laws" describes that (it is a bit overly broad, as Novartis did not challenge the entire body of law, but rather some provisions) but is still relatively NPOV. Your change to "Preventing Indian citizens from access to cheaper generic medicines" makes it appear that their goal was actually to harm Indian citizens which is a) not accurate and b) POV. I do understand that if Novartis had won, Indian citizens would have been prevented from access to some generic drugs - but certainly not all. Your change also makes it appear that this was their goal - to remove access to all generics. So I reverted this too. Please explain how to your change to the section header is a) accurate and b) complies with NPOV.Jytdog (talk) 09:46, 17 October 2013 (UTC)
3. Your use of the {{subst:main}} template is not correct. That template is used to refer to another Misplaced Pages article, not to a source. Sources are used to support content, and end up in footnotes. If there was an especially key publication about an issue, the publication itself could be discussed in the article content - but you would need a second source then, to show the importance of the first source. I also want to note that the source you put there is not an NPOV, reliable source, but instead was the website of a campaign run by Doctors without Borders, opposed to Novartis. This source is not a NPOV, reliable source, right? If you would like to create NPOV content about MsF campaign, that is fine, but that content needs to be backed up with reliable sources from third parties, showing that the campaign was notable in its own right. Jytdog (talk) 09:46, 17 October 2013 (UTC)

Hope that makes sense. Happy to discuss. Jytdog (talk) 09:46, 17 October 2013 (UTC)

• All unassessed articles
• C-Class company articles
• Unknown-importance company articles
• WikiProject Companies articles
• C-Class WikiProject Business articles
• Unknown-importance WikiProject Business articles
• WikiProject Business articles
• C-Class pharmacology articles
• High-importance pharmacology articles
• WikiProject Pharmacology articles
• C-Class Switzerland articles
• High-importance Switzerland articles
• All WikiProject Switzerland pages